Skip to main content
Log in

Protein synthesis and urokinase mRNA metabolism

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Expression of the urokinase-type plasminogen activator (uPA) is under tight regulation by hormones, cytokines and growth factors under physiological conditions. Treatment of lung epithelial (Beas2B) cells with translation inhibitors induces uPA mRNA expression, as well as early response genes. To understand the specific expression and regulation of uPA mRNA, we treated Beas2B cells with cycloheximide (CycD), anisomycin, emitine and puromycin in a time-dependent manner and measured uPA mRNA expression by Northern blotting. All these agents induced uPA mRNA by two- to seven-fold within 3 h after treatment in Beas2B cells. CycD, emitine, puromycin and anisomycin also enhanced uPA mRNA half-life by three- to five-fold in Beas2B cells treated with DRB, an inhibitor of transcription. However, run-on-transcription experiments indicated that these agents failed to induce uPA mRNA transcription indicating that they augment uPA mRNA mainly due to increased stability. Using gel mobility shift, we identified an uPA mRNA binding protein (uPA mRNABp) that selectively binds to uPA mRNA [Gyetko MR, Todd III RF, Wilkinson CC, Sitrin RG: The urokinase receptor is required for human monocyte chemotaxis In vitro. J Clin Invest 93: 1380–1387, 1994]. Binding of both cytoplasmic and nuclear uPA mRNABp to uPA mRNA was abolished after treatment with translation inhibitors, which coincides with the maximal expression of uPA mRNA. We also found a similar decline in HuR and heterogeneous nuclear ribonucleoprotein C (hnRNPC) which are known to stabilize uPA mRNA both in the nuclear and cytosolic compartments. These results strongly suggest that increased uPA mRNA stability induced by translational inhibitors involves the interaction of uPA mRNA with a degrading protein factor rather than increased interaction of proteins that are known to stabilize uPA mRNA. These data also strongly suggests that down-regulation of the uPA-uPA mRNABp interaction by translational inhibitors rather than the translocation of uPA mRNABp contributes to increased uPA mRNA stability. This pathway may regulate uPA-mediated functions of the lung epithelium in the context of inflammation or neoplasia. (Mol Cell Biochem 271: 13–22, 2005)

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

Bronchial epithelial cells:

Beas2B

tumor necrosis factor alpha:

TNF-α

transforming growth factor-beta:

TGF-β

heterogeneous Nuclear Ribonucleoprotein C:

hnRNPC

cycloheximide D:

CycD

messenger mRNA binding protein:

mRNABp

urokinase-type plasminogen activator:

uPA

ribonucleic acid:

RNA

fetal calf serum:

FCS

sodium dodecyl sulfate:

SDS

polyacrylamide gel electrophoresis:

PAGE

free probe:

Fp

untranslated region:

UTR

References

  1. Gyetko MR, Todd III RF, Wilkinson CC, Sitrin RG: The urokinase receptor is required for human monocyte chemotaxis in vitro. J Clin Invest 931380–1387, 1994

    Google Scholar 

  2. Gyetko MR, Sitrin RG, Fuller JA, Todd III RF, Petty H, Standiford TJ: Function of the urokinase receptor (CD87) in neutrophil chemotaxis. J Leuk Biol 58533–538, 1995

    Google Scholar 

  3. Dumler I, Weis A, Mayboroda OA et al.: The Jak/Stat pathway and urokinase receptor signaling in human aortic vascular smooth muscle cells. J Biol Chem 273(1): 315–321, 1998

    Google Scholar 

  4. Koshelnick Y, Ehart M, Hufnagl P, Heinrich PC, Binder BR: Urokinase receptor is associated with the components of JAK1/STAT1 signaling pathway and leads to activation of this pathway upon receptor clustering in the human kidney epithelial tumor cell line TCL-598. J Biol Chem 272(45): 28563–28567, 1997

    Google Scholar 

  5. Chapman H: Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr Opin Cell Biol 9: 714–724, 1997

    Google Scholar 

  6. Shetty S, Idell S: Posttranscriptional regulation of urokinase mRNA: Identification of a novel urokinase mRNA-binding protein in human lung epithelial cells in vitro. J Biol Chem 27513771–13779, 2000

    Google Scholar 

  7. Altus MS, Nagamine Y: Protein synthesis inhibition stabilizes urokinase-type plasminogen activator mRNA. J Biol Chem 26621190–21196, 1991

    Google Scholar 

  8. Akashi M, Shaw G, Gross M, Saito, M, Koeffler HP: Role of AUUU sequences in stabilization of granulocyte-macrophage colony-stimulating factor RNA in stimulated cells. Blood 782005–2012, 1991

    Google Scholar 

  9. Caput D, Beutler B, Hortog K, Thayer R, Brown-Shimer, S, Cerami: A Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci USA 831670–1674, 1986

    CAS  PubMed  Google Scholar 

  10. Shaw G, Kamen RA: conserved AU sequence from the 3′untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46659–667, 1986

    Article  CAS  PubMed  Google Scholar 

  11. Jones TR, Cole MD: Rapid cytoplasmic turnover of c-myc mRNA; requirement of the 3′untanslated sequences. Mol Cell Biol 74513–4521, 1987

    Google Scholar 

  12. Wang GJ, Collinge M, Blasi F, Pardi R, Bender JR: Posttranscriptional regulation of urokinase plasminogen activator receptor messenger RNA levels by leukocyte integrin engagement. Proc Natl Acad Sci USA 95, 6296–6301, 1998

    Google Scholar 

  13. Nanbu R, Menoud P-A, Nagamine Y: Multiple instability-regulating sites in the 3′untranslated region of the urokinase-type plasminogen activator mRNA. Mol Cell Biol 144920–4928, 1994

    Google Scholar 

  14. Heaton JH, Tillman-Bogush M, Leff NS, Gelehrter TD: Cyclic nucleotide regulation of type-1 plasminogen activator-inhibitor mRNA stability in rat hepatoma cells. J Biol Chem 273, 14261–14268, 1998

    Google Scholar 

  15. Tillman-Bogush M, Heaton JH, Gelehrter TD: Cyclic nucleotide regulation of PAI-1 mRNA stability Identification of cytosolic proteins that interact with an A-Rich sequence. J Biol Chem 2741172–1179, 1999

    Google Scholar 

  16. Maurer F, Tiernay M, Medcalf RL: An AU-rich sequence in the 3′-UTR of plasminogen activator inhibitor type 2 (PAI-2) mRNA promotes PAI-2 mRNA decay and provides a binding site for nuclear HuR. Nucl Acid Res 271664–1673, 1999

    Google Scholar 

  17. Wilson T, Triesman R: Removal of poly (A) and consequent degradation of c-fos mRNA facilitated by 3′AU-rich sequences. Nature 336396–399, 1988

    Google Scholar 

  18. Casey JL, Koeller DM, Ramin VC, Klausner RD, Harford JB: Iron regulation of transferrin receptor mRNA levels requires iron-responsive elements and a rapid turnover determinant in the 3′ untranslated region of the mRNA. EMBO J 123693–3699, 1989

    Google Scholar 

  19. Mullner EW, Kuhn LC: A stem-loop in the 3′untranslated region mediates iron-dependent regulation of transferrin receptor mRNA stability in the cytoplasm. Cell 53815–825, 1988

    Google Scholar 

  20. Levine BJ, Chodchoy N, Marzluff WF, Skoultchi AI: Coupling of replication type histone mRNA levels to DNA synthesis requires the stem-loop sequence at the 3′ end of the mRNA. Proc Natl Acad Sci 846189–6193, 1987

    Google Scholar 

  21. Iwai Y, Akahane K, Cohen, RB: Ca ionophore A23187-dependent stabilization of granulocyte-macrophage colony-stimulating factor messenger RNA in murine thymoma EL-4 cells is mediated through two distinct regions in the 3′-untranslated region. J Immunol 1504386–4394, 1993

    Google Scholar 

  22. Parkar R, Jacobson A: Translation and a 42-nucleotide segment within the coding region of the mRNA encoded by the MATα1 gene are involved in promoting rapid mRNA decay in yeast. Proc Natl Acad Sci USA 872780–2784, 1990

    Google Scholar 

  23. Shetty S, Kumar A, Idell S: Posttranscriptional regulation of urokinase receptor mRNA: Identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells. Mol Cell Biol 171075–1083, 1997

    Google Scholar 

  24. Montuori N, Mattiello A, Mancini A, Santoli M, Taglialatela P, Caputi M, Rossi G, Ragno P: urokinase-type plasminogen activator up-regulates the expression of its cellular receptor through a posttranscriptional mechanism. FEBS Lett 508379–384, 2001

    Google Scholar 

  25. Tiernay M, Medcalf RL: Plasminogen activator inhibitor type 2 contains mRNA instability elements within exon 4 of the coding region. J Biol Chem 27613675–13684, 2001

    Google Scholar 

  26. Davis CA, Monnier JM, Nick HS: A coding region determinant of instability regulates levels of manganese superoxide dismutase mRNA. J Biol Chem 27637317–37326, 2001

    Google Scholar 

  27. Altus, MS, Nagamine Y: Protein synthesis inhibition stabilizes urokinase-type plasminogen activator mRNA. Studies in vivo and in cell-free decay reactions. J Biol Chem 26621190–21196, 1991

    Google Scholar 

  28. Ziegler A, Knesel J, Fabbro D, Nagamine Y: Protein kinase C down-regulation enhances cAMP-mediated induction of urokinase-type plasminogen activator mRNA in LLC-PK1 cells. J Biol Chem 26621067–21074, 1991

    Google Scholar 

  29. Henderson BR, McDonald DA, Kefford RF: Posttranscriptional regulation of urokinase plasminogen activator gene expression occurs in the nucleus of BC1 rat mammary tumor cells. Int J Cancer 50918–923, 1992

    Google Scholar 

  30. Henderson BR, Tansey WP, Phillips SM, Ramshaw IA, Kefford RF: Transcriptional and posttranscriptional activation of urokinase plasminogen activator gene expression in mestatic tumor cells. Cancer Res 522489–2496, 1992

    Google Scholar 

  31. Shetty S, Idell S: Urokinase induces expression of its own receptor in Beas2B lung epithelial cells. J Biol Chem 27624549–24556, 2001

    Google Scholar 

  32. Shetty S, Bdeir K Cines D, Idell S: Induction of plasminogen activator inhibitor-1 by urokinase in lung epithelial cells. J Biol Chem 27818124–18131, 2003

    Google Scholar 

  33. Antalis TM, Godbolt D: Isolation of intact nuclei from hematopoietic cell types. Nucl Acid Res 194301, 1991

  34. Shetty S: Cytoplasmic-nuclear shuttling of the urokinase mRNA binding protein regulates message stability. Mol Cell Biochem 23755–67, 2002

    Article  CAS  PubMed  Google Scholar 

  35. Tran H, Maurer F, Nagamine Y: Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated kinase 2. Mol Cell Biol 237177–7188, 2003

    Google Scholar 

  36. Nanbu R, Montero, L., D’Orazio D, Nagamine Y: Enhanced stability of urokinase-type plasminogen activator mRNA in metastatic breast cancer MDA-MB-231 cells and LLC-PK1, cells down-regulated for protein kinase C. Eur J Biochem 247169–174, 1997

    Google Scholar 

  37. Marshall BC, Xu Q-P, Rao NV, Brown BR, Hoidal JR: Pulmonary epithelial Cell urokinase-type plasminogen activator. J Biol Chem 26711462–11469, 1990

    Google Scholar 

  38. Saksel O: Plasminogen activation and regulation of pericellular proteolysis. Biochim Biophys Acta 82335–65, 1985

    Google Scholar 

  39. Blasi F, Vassali JD, Dano K: Urokinase-type plasminogen activatorProenzyme, receptor, and inhibitors. J Biol Chem 104801–804, 1987

    Google Scholar 

  40. Wang Z, Kiledjian M: Identification of erythroid-enriched endoribonuclease activity involved in specific mRNA cleavage EMBO J 19295–305, 2000

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sreerama Shetty.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shetty, S. Protein synthesis and urokinase mRNA metabolism. Mol Cell Biochem 271, 13–22 (2005). https://doi.org/10.1007/s11010-005-3453-x

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-005-3453-x

Key words

Navigation